Gene Query: GRPEL2

Dataset Description Geneva Score
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 154.87
RNAseq analysis of ESRP regulated splicing events in prostate cancer 75.32
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 69.05
Human HAP1 cells before and after nutrient deprivation 48.91
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 48.91
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 42.01
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 40.86
Differential expression of genes in AD169-infected MRC5. 39.04
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 38.23
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 37.02
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 33.27
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 33.27
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 30.32
Gene expression analysis of dengue-infected cells 29.08
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 25.59
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 23.08
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 22.89
Tracking of dCas9-methyltransferase footprints 21.78
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 21.29
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 21.01
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 20.75
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 20.75
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 20.58
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 20.4
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 20.1
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 19.69
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 19.69
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 19.49
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 19.41
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 18.37
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 18.37
Transcriptome analysis in Neobractatin treated cells 17.99
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 17.94
EP400 is required for Max and MCPyV mediated gene activation 17.7
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 17.26
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 17.19
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 16.69
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 16.63
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 16.46
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 16.18
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 16.18
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 16.01
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 16.01
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 15.86
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 15.64
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 15.6
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 15.5
Altering cancer transcriptomes using epigenomic inhibitors 15.5
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 15.34
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 15.3
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.98
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 14.77
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 14.76
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 14.55
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 14.52
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 14.37
RNAseq Study in CC-671 Treated Cal-51 Cells 14.05
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 13.91
The human blood-nerve barrier transcriptome 13.67
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 13.62
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 13.62
IRF1 regulates IFN dependent and independent gene expression 13.37
Overexpression of NFIB and YBX1 in MCF-7 cells 13.28
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 13.12
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 13.03
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 13.02
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 12.82
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 12.71
IMP3 regulated gene expression in breast cancer cells 12.64
RNA sequencing of GlyH-101-treated MCF-7 cell line 12.5
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 12.35
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 12.06
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 12.02
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 11.99
Role of COP1 on MAP kinase transcriptional output in melanoma 11.82
m6A-dependent regulation of messenger RNA stability 11.58
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.54
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 11.53
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 11.44
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 11.4
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 11.4
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 11.35
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.3
Gene expression in PANC1 cells treated with Rakicidin 11.3
U1 snRNP telescripting regulates size-function stratified human genome 11.27
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 11.26
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 11.24
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 11.1
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 11.1
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 11.05
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 10.99
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 10.99
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 10.92
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 10.82
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 10.5
Depicting early human development and germ cell origin with porcine embryos 10.5
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 10.42
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 10.38
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 10.32
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 10.2
Knockdown of ADNP in HCT116 colon cancer cells 10.18
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.16
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 10.16
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 10.14
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 10.02
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 9.98
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 9.95
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 9.94
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 9.91
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 9.91
RNA-Seq with and without RNase treatment in PCa cell lines 9.9
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 9.87
EWSR1 influences alternative splicing through direct and indirect mechanisms 9.84
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 9.77
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 9.74
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 9.74
Effect of from Human Umbilical Vein Endothelial Cells 9.68
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 9.62
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 9.58
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 9.52
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 9.52
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.34
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.33
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 9.27
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 9.25
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.24
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 9.2
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 9.09
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 9.09
RNA expression analysis upon JMJD1C depletion 9.09
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 9.09
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 9.05
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.04
Hepatitis C virus functionally sequesters miR-122 8.94
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 8.94
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 8.93
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 8.9
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 8.9
Differentially expressed genes post knock down of lincDUSP26 8.9
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 8.89
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.88
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.75
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.75
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.67
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 8.62
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 8.52
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 8.39
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 8.37
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 8.37
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 8.33
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 8.24
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 8.22
CircRNAome diversity in human mature B-cells, T-cells and monocytes 8.11
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 8.11
A Unique Epigenomic Landscape Defines Human Erythropoiesis 8.11
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 8.02
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 8.01
nELAVL HITS-CLIP in Alzheimer's Disease patients 7.97
The landscape of alternative splicing in aggressive prostate cancers 7.93
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.86
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 7.84
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 7.83
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 7.82
LIN28A modulates splicing and gene expression programs in breast cancer cells 7.82
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 7.81
3’ Uridylation Expands miRNA Target Repertoire 7.79
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 7.76
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 7.74
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 7.74
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 7.73
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.66
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 7.65
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.64
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 7.6
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 7.6
Systematic discovery of endogenous human ribonucleoprotein complexes 7.57
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 7.55
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 7.55
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 7.54
LNCaP treated with iBET 7.54
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 7.53
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.44
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.44
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 7.43
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 7.39
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.39
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 7.37
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 7.33
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.31
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 7.25
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 7.24
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 7.22
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.16
SLIGRL-induced gene expression changes in NHEK cells 7.15
Human cell line and subcutaneous tumor 7.14
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 7.13
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 7.13
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.09
HEK293 TFAM Knockout Expression Study 7.02
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.02
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 7.0
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 7.0
Effect of FGF13 depletion on the H460 cell line 6.93
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 6.92
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 6.87
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 6.83
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 6.79
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.79
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 6.78
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.77
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.74
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.69
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 6.68
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 6.68
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 6.62
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.6
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.58
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 6.58
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 6.54
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.54
Effect of PBK knockdown on C4-2 cell transcriptome 6.51
R430: A potent inbibitor of DNA and RNA viruses 6.48
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.47
The pause-initiation limit restricts transcription activation in human cells 6.42
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 6.41
BAF controls genome accessibility 6.36
Cleavage Factor Im as a key regulator of 3’ UTR length 6.34
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.33
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.33
Gene expression profiling of leukemia cells following asparagine depletion 6.28
ADAR1-editing of cellular and measles virus-derived duplex RNA 6.27
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 6.27
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 6.25
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 6.23
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 6.23
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 6.16
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 6.07
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.06
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 6.06
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 6.04
Genome-wide discovery of human splicing branchpoints [RNAse] 5.99
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 5.98
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.93
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 5.91
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.89
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.86
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.86
Regulation of Lipids is Central to Replicative Senescence 5.83
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 5.82
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 5.81
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 5.81
CD73 knockdown effect in pancreatic cancer cell lines 5.79
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 5.78
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 5.78
mRNA recovered upon RNF219 IP. [RNA-IP] 5.75
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 5.75
Chromatin-informed inference of transcriptional programs in gynecologic cancers 5.74
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 5.74
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.73
Human embryonic stem cells in E8 and AKIT culture medium 5.73
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 5.73
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 5.72
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.6
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 5.59
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 5.59
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 5.59
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 5.58
Determining mRNA half-lives on a transcriptome-wide scale 5.58
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 5.58
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.58
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.58
RNA-seq of naive and primed ES cells (NHSM) 5.58
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.56
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 5.5
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 5.5
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.48
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 5.44
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 5.44
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 5.41
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.4
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  5.38
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 5.38
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.38
RNAseq of T-ALL upon long non coding rna purturbation 5.36
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 5.35
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.35
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.35
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.33
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 5.32
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 5.32
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.3
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.3
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 5.2
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.2
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 5.17
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.16
Mapping interactions for the TNIP2 hub protein 5.15
Splicing and epigenetic factors jointly regulate epidermal differentiation 5.12
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 5.11
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 5.06
Transcriptome profiling of Normal and Cancerous Prostate Cells 4.98
LIN28A Over-expression RNAseq 4.96
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.89
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 4.87
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.82
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.82
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 4.8
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 4.8
Transcriptome of U251 cells overexpression complement component 7 4.78
The cohesin complex prevents Myc-induced replication stress 4.75
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.72
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 4.7
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.66
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 4.66
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.64
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.64
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.59
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 4.58
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 4.58
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.55
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.54
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.54
Cajal bodies are linked to genome conformation 4.52
Cajal bodies are linked to genome conformation [RNA-Seq] 4.52
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.51
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.51
U2AF1 mutations alter splice site recognition in hematological malignancies 4.48
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.46
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.46
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 4.45
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.42
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.42
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.42
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 4.39
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 4.36
DART-seq: an antibody-free method for global m6A detection 4.3
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 4.29
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 4.29
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.25
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.24
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.24
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.24
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 4.19
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.16
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.13
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.12
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.1
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.07
FBXW7 modulates stress response by post-translational modification of HSF1 4.07
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 4.06
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 4.06
HNRNPM-regulated splicing dependencies in prostate cancer 4.06
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.06
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.03
CDK4/6 inhibitor resistance in prostate cancer 4.01
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 4.0
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.92
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.89
N6-methyladenine DNA Modification in Glioblastoma 3.89
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.88
Determination of tRNA aminoacylation levels by high throughput sequencing 3.86
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.84
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.83
Transcriptome analysis upon C6orf203 silencing 3.8
Effect of CHKA knockdown on C4-2 cell transcriptome 3.73
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 3.67
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.61
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 3.58
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 3.58
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 3.56
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 3.56
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.54
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.52
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.47
SLAM-seq for K562 endogenous mRNA decay 3.45
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 3.41
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.41
Oncogenic roles of ARID5B in T-ALL 3.39
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 3.39
Differential Protein Occupancy Profiling of the mRNA Transcriptome 3.36
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.28
Identification of HOXB13 target genes responsive to BET inhibitors 3.16
PRDM1 inhibits proliferation of human colon cancer organoids 3.14
The circadian transcriptional landscape in primary human mammary epithelial cells 3.13
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.12
The cytokine environment influence on human skin-derived T cells 3.11
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 3.09
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.07
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.07
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.98
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.98
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 2.97
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.91
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.84
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.83
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.82
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 2.78
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.77
Direct Isolation and Characterization of Human Nephron Progenitors. 2.7
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.66
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.66
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.66
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.65
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.62
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.6
Transcriptome-wide identification of CELF2 functional targets in T cells 2.58
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.55
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.54
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 2.54
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.49
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 2.42
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.38
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.34
RNA sequencing of human mammary epithelial cells 2.31
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.3
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.27
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.27
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.16
The cohesin release factor WAPL restricts chromatin loop extension. 2.15
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.15
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 2.12
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.99
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 1.96
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.87
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 1.87
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.86
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.86
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.82
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 1.81
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.78
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.77
CDK12 mediated transcriptional regulation in U2OS cells 1.69
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.68
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.63
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.62
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.6
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.57
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.51
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.49
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.43
Gene expression profile of CRC-derived HILEC 1.36
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.35
Global transcriptome analysis of WT versus HEB-/- hESCs 1.29
Generation of KRAS signatures using immortalized isogenic lung cells. 1.29
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.28
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.26
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.25
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.25
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.25
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  1.15
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.09
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.09
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.09
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.97
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.93
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.86
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.8
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.79
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.77
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.76
Modulation of nonsense-mediated decay by rapamycin 0.71
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.7
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.66
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.66
Human Treg IFNg/IL-10 subpopulations 0.65
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.64
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.64
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.61
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.6
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.58
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.55
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.53
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.52
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.51
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.51
Gene expression changes due to PARP knockdown in human cells 0.48
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.45
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.44
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.44
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.42
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.41
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.38
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.37
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.31
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.31
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.3
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.25
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.25
Transcriptomic analysis of LSD1 0.2
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.19
HBEC-shp53-PCHD7 0.19
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.13
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.13
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.1
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation